Related Experiment Videos

Pathophysiology of catecholamine-mediated myocardial damage

R S Eliot, G L Todd, G M Pieper

Journal of the South Carolina Medical Association (1975)

|November 1, 1979

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.

Oncogene·2007

Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein in cardiac transplant rejection.

Antioxidants & redox signaling·2001

Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction.

European journal of pharmacology·2000

Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse.

European journal of pharmacology·2000

Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival.

Journal of cardiovascular pharmacology·2000

Biological evaluation of the nitric oxide-trapping agent, N-methyl-D-glucamine dithiocarbamate-Fe2+, as a probe of nitric oxide activity released from control and diabetic rat endothelium.

Japanese journal of pharmacology·1999

See all related articles